In 2024, Newport’s treatment yielded remarkable improvements in adolescent and young adult patients’ depressive and anxiety symptoms, subjective wellbeing, suicide risk, traumatic distress, and attachment to parents/caregivers. Highlights include:
f Well-being improved from “poor” to “well” for adolescent residential patients with anxiety and/or depression
f The number of adolescents experiencing suicidal thoughts dropped by 50% over five weeks of treatment
f The number of young adults with suicide plans fell from 1 in 10 to 1 in 100 over 12 weeks of outpatient treatment
f 95% of referring professionals reported that the patients they referred received exceptional care
f Newport post-discharge data showed that gains made in residential treatment were maintained 90 days after discharge
f Almost half of PrairieCare’s TMS patients experienced at least a 50% reduction in depressive symptoms
How We Achieve IndustryLeading Outcomes
Newport uses a results-driven treatment model, facilitated by clinicians trained and supervised in evidence-based and empirically validated therapeutic modalities (Attachment-Based Family Therapy, EMDR, Dialectical Behavioral Therapy–informed skills, Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and more).
Our treatment teams incorporate a wide variety of specializations—clinical, medical, psychiatric, experiential, dietary, life skills, and academic— to create transformative care experiences with sustainable results.
A Message From Our CEO
As our nation’s youth and young adult mental health crisis continues, Newport Healthcare remains steadfast in our commitment to lead the way in long-term healing. We are proud to share our exceptional 2024 outcomes that reflect the unwavering dedication of our multidisciplinary teams, whose expertise and compassion set us apart in the industry.
Measuring our outcomes is more than a benchmark; it’s a way for us to showcase the tangible difference we make in the lives of those we serve—the young people and families whose futures are brighter because of the healing we help inspire. And we continue to grow that impact, by expanding our services, our locations, and our partnerships with insurance providers, making our transformative care more accessible to individuals and families across the nation.
Brian Setzer, CEO Newport Healthcare
Echo Lake, WA
Patient Profiles: Adolescents & Young Adults
Patient Profiles: Adolescents + Young Adults
This section includes diagnoses, demographics, and risk factors among our adolescent patients at Newport Academy (ages 12–18*) and our young adult patients at Newport Institute (ages 18–35).
Text goes here Uciet qui de optas remodi blate molupta eperum cum inum ipsam il eosandi none ditia in cumet quodipid untem alitium quasperibus eum escim as ad min custiae cearum
nihillabore ipitis apist enditat emperibus qui nus autemod
*In 2024, Newport Academy began providing residential and outpatient treatment for children ages 7–11. This report does not include treatment outcomes data for ages 7–11.
Risk Factors & Symptomology
Substance Use Bullying
Substance use often serves as an unhealthy coping mechanism for emotional discomfort and distress. Newport's residential patients report higher levels of substance use than those in outpatient care.
To deepen our insight into our patients’ experiences and challenges, our surveys ask about their exposure to various risk factors and their engagement in unhealthy coping behaviors that may undermine their relationships and well-being. 60% 30%
1 in 4 adolescents
1 in 3 young adults
in residential care answered yes to the question “Have you ever used any type of substance or medicine to get high or relax?"
Bullying is a common risk factor for Newport’s adolescent patients, as shown below. Research finds that being bullied is linked to a greater risk of mental health issues and suicidal behavior.
reported cyberbullying
reported verbal bullying
Family Conflict Adolescent Screen Use
Many patients report family conflict and lack of communication. Our treatment seeks to restore trust and connection, so family can be a source of support.
To measure the impact of screen use on mood and relationships, we surveyed our adolescent residential patients about their related emotions and conflicts.
4 out of 10
7 out of 10 adolescents and young adults in outpatient care reported not getting along with their family adolescent and young adult patients in residential care reported they could not talk with their family about the sadness they feel
feel they spend more time on their devices than necessary feel uncomfortable when they are unable to use their devices
49% 25% 24%
argue with parents/caregivers about their device use
Anxiety (GAD-7) Average Score
Anxiety (GAD-7)
In tracking anxiety outcomes, we measured improvements in patients who reported elevated symptoms of anxiety (moderate to severe) at intake. To address anxiety, we use modalities including Cognitive Behavioral Therapy, Dialectical Behavioral Therapy–informed skills, and Acceptance and Commitment Therapy to help adolescents examine and reframe negative thoughts and fears, and develop positive coping skills. On average, patients’ anxiety scores fell from severe to moderate levels by week 3, and to mild levels by week 5. Patients experienced, on average, a statistically significant decrease in GAD-7 scores at each subsequent timepoint from intake to week 5.
Interpretation of the Levels
15–21: Severe
10–14: Moderate
5–9: Mild
RESULTS:
Extended Stays & Post-Discharge Outcomes
5
Most adolescent patients were discharged by week 7; however, those who needed additional time in treatment continued to report fewer depression and anxiety symptoms and increased well-being levels through week 9. Compared to intake scores, patients maintained their improvements, on average, across all three measures 180 days post-discharge—illustrating that Newport’s treatment model can create long-term recovery. Intake Week 3
EXTENDED STAYS
Anxiety: p value (statistical significance) < .001; see p. 37 for details.
POST-DISCHARGE OUTCOMES
Well-Being (WHO-5)
At intake, adolescent residential patients reported poor well-being, on average (score of 11.6). By week 3, their scores were in the well range (13.9), and this further improved by week 5 (15.2). Patients with depression or anxiety reported even lower well-being at intake (8.6) and experienced statistically significant increases over the course of residential treatment, reaching the well range (13.6) by week 5. By looking at the increase in the percentage of patients reporting improvements in various aspects of well-being from intake to week 5, we can see how the impact of treatment is reflected in patients’ mindset, energy levels, and engagement with daily life.
Interpretation of the Levels
0–7: Likely Depression
8–12: Poor Well-Being
13–25: Well
WHO-5 CHANGES: PATIENTS WITH DEPRESSION
WHO-5 CHANGES: PATIENTS WITH ANXIETY
Intake Week 5
Percentages indicate the number of patients who endorse feeling each item “more than half the time.” Well-being: p value (statistical significance) < .001; see p. 37 for details.
Academics (NAS)
For many adolescents, anxiety and depression reduce cognitive abilities and focus, which can derail academic motivation and success. Newport’s accredited academic curriculum provides instruction and tutoring 3–4 hours per day, Monday–Friday. Our teaching teams support patients to close learning gaps and nurture their talents and interests, while also addressing psychological factors that impact academics, such as school-related anxiety, lack of coping strategies, and executive functioning deficits.
Interpretation
of the Levels
The Newport Academic Scale (NAS) measures three components, with 20 points maximum per component.
RESULTS:
General Functioning
In 2024, our surveys included questions asking patients about their general functioning across various areas of life. General functioning is defined as an individual’s ability to cope with everyday demands. At intake and again 30 days post-discharge, adolescents used a scale of 0–10 to indicate how they had been doing over the past four weeks across six domains. In the post-discharge survey, our alumni reported higher functioning in all domains, reflecting Newport’s focus on helping adolescents build healthy coping skills and authentic relationships.
Alumni Experience
“Participating in everyday life at Newport brought me the ability to manage my time more efficiently and provide a more consistent routine that supports me in recovery. Newport has opened up so many doors in my life, and I am forever grateful.”
—David V.
Interpersonal Skills Study Skills Motivation
Scale of 0–10
RESULTS:
Anxiety (GAD-7)
More than half of Newport’s young adult patients had a secondary diagnosis of anxiety at intake, about 13% had a primary diagnosis, and two-thirds reported severe anxiety symptoms on the GAD-7 assessment. Among patients reporting elevated anxiety, symptoms dropped to a moderate level, on average, by week 3, and further improved by week 5.
Interpretation of the Levels
15–21: Severe
10–14: Moderate
5–9: Mild
RESULTS:
Traumatic Distress (BHS)
Traumatic distress refers to emotional and behavioral symptoms resulting from traumatic experiences, such as sexual coercion or domestic abuse. At intake, over half of young adults reported symptoms of traumatic distress, such as being on guard/watchful, losing interest in activities that reminded them of past trauma, and avoiding reminders of traumatic experiences. In addition, 50% reported having nightmares. After just three weeks of Newport treatment, young adult patients reported improvements in all symptoms. By week 5, traumatic distress symptoms had further improved, as young adults addressed underlying trauma and gained healthy coping skills.
Anxiety (GAD-7)
Average Score
Intake Week 3 Week 5
HOW WE TREAT ANXIETY AND TRAUMA
Newport’s clinical model treats anxiety and trauma through tailored treatment plans that include psychiatric care and medication management, Cognitive Behavioral Therapy to change negative thought patterns, EMDR to reduce the intensity of traumatic memories, and psychoeducation to help young adults better understand how the brain and body respond to stress.
Alumni Experience
“Getting sober and healthy has brought me back up to speed and my memory is back. I treasure it now, all of the moments I thought once lost to time. The memories of the life I lived are now accessible to me again.”
—John F.
Anxiety: p value (statistical significance) < .01; see p. 37 for details.
RESULTS:
Therapeutic Alliance (WAI-SR)
Connection between therapist and patient is vital to the success of treatment, creating a foundation of trust and safety that allows patients to look honestly at their experiences and build the courage to make positive change. At week 3, most young adult patients had already established mutual respect and collaboration with their therapist. From week 3 to week 5, alliance improved in all 12 categories on the assessment, with the most notable increases in the items “I have a better idea of how I might be able to make some changes” and “Therapy gives me new ways of looking at my problem.”
RESULTS:
Extended Stays & Post-Discharge Outcomes
Most young adult patients were discharged by week 7; however, those who needed more time in treatment experienced additional improvements in depression, anxiety, and well-being. Post-discharge data shows that young adults maintained improvements, on average, after treatment, with all measures consistent or improved between day 30 and day 180. The data illustrates that the changes patients make within safe and caring therapeutic environments lead to long-term positive outcomes.
Alumni Experience
“After being at Newport for only a few days and seeing what groups were like and who my support team was, I knew I was in the right place. I never knew how much I needed to learn, and I will be forever grateful to Newport for starting me on this path.”
—Chelsea W.
RESULTS:
Well-Being (WHO-5)
Patients, on average, reported poor well-being at intake, which improved to the “well” range (13.2) by day 51. For those with anxiety or depression, well-being at intake was lower (8.5) and improved throughout treatment, to just below the “well” range. Adolescents in outpatient care experienced substantial well-being increases, on average, as reflected in individual WHO-5 measures, as seen below. Our outpatient care provides ongoing support and structure for patients and their families, to enhance adolescents’ self-esteem and build greater harmony within the family unit.
WHO-5 CHANGES: PATIENTS WITH DEPRESSION
Interpretation of the Levels
0–7: Likely Depression
8–12: Poor Well-Being
13–25: Well
WHO-5 CHANGES: PATIENTS WITH ANXIETY
Intake Day 51
Percentages indicate the number of patients who endorse feeling each item “more than half the time.” Well-being, depression, anxiety: p value (statistical significance) < .05; see p. 37 for details.
Adolescent well-being scores, on average, increased from “poor” to “well” over 51 days of outpatient treatment.
RESULTS:
Family Relationships & Attachment (ECR-RS)
Our outpatient treatment includes Attachment-Based Family Therapy to repair ruptures in the parent-child relationship, leading to improvements in patients’ attachment to both maternal and paternal figures (including stepparents, grandparents, etc.). As treatment progressed, patients became more comfortable discussing problems and concerns with parental figures, and turning to them in times of need. Our emphasis on family engagement and our collaborative approach aim to create an environment in which patients and families feel heard, supported, and connected.
RESULTS:
Therapeutic Alliance (WAI-SR)
By day 21, adolescents in outpatient care had, on average, made solid alliances with their family therapist (score of 45 on a scale of 0–60), and working alliance was even stronger by day 51 (47). Patients felt they were respected and liked by their family therapist, and agreed with their therapist on changes that needed to be made and how to make them. The therapist-patient alliance supports strong engagement in the therapeutic process and provides a safe space in which patients can experience meaningful growth and shift old patterns of thinking and acting.
RESULTS:
General Functioning
General functioning refers to how well adolescents are doing in their daily activities. Newport measures six domains when evaluating the adolescent general functioning scale: engagement at school, friendships, emotions, family relationships, trust and openness with family, and hope for the future. From intake to 30 days post-discharge, patients showed improvement across all domains. In outpatient care, adolescents gain healthy coping, relationship, and self-awareness skills that they can put into practice right away, transforming their lives and relationships.
Alumni Experience
“My daughter put in a lot of work every day and it started to show. Not only how she talked, but how she interacted in conversation. She was excited to use the tools she had learned through her therapy and interactions with other kids. Her humor made a comeback as well. I cherished every moment I saw her smiling again!”
—Joey P., alumni parent
RESULTS:
Well-Being (WHO-5)
From intake to day 51 of outpatient treatment, young adult patients, on average, experienced well-being increases. Those with elevated symptoms of anxiety and/or depression made even more significant improvements in wellbeing, with average scores increasing from the low end of the “poor” range (around 8) to the high end (close to 12). Within a compassionate, supportive environment, young adults begin to feel a sense of connection, belonging, and hope. Looking at individual WHO-5 measures, below, we see gains across all well-being symptoms, with more than half of patients feeling calm, relaxed, and engaged with daily life.
Darien, CT
Interpretation of the Levels
0–7: Likely Depression
8–12: Poor Well-Being
13–25: Well
WHO-5 CHANGES: PATIENTS WITH DEPRESSION
WHO-5 CHANGES: PATIENTS WITH ANXIETY
Intake Day 51
Percentages indicate the number of patients who endorse feeling each item “more than half the time.” Well-being: p value (statistical significance) < .05 for all patients, <.01 for patients with depression, <.001 for patients with anxiety; see p. 37 for details.
RESULTS:
Family Relationships & Attachment (ECR-RS)
Attachment-Based Family Therapy is an essential component of Newport’s outpatient treatment plans, as a strong family support system provides a powerful foundation for young adult mental health. Repairing ruptures in relationships with family members—most often, parental figures, such as parents, grandparents, stepparents, etc.—can heal longstanding wounds and promote young adults' overall healng. Patients’ family attachment measures improved throughout treatment, with young adults feeling:
More likely to discuss problems and concerns with parents and turn to them in times of need
More comfortable opening up to parents and sharing how they really feel
Less worried that parental figures would abandon them or don’t care about them
More likely to depend on parents and talk things over with them
RESULTS:
Therapeutic Alliance (WAI-SR)
Young adults in our outpatient care responded to 12 different items related to alliance with their family therapist (see page 14). By day 21, patients had already forged a high working alliance with their therapist, with an average score of 43 on a scale of 0–60. Agreement and collaboration between patient and therapist further improved between days 21 and 51. Newport’s family therapists and other clinical experts bring a wide variety of specializations, backgrounds, and experience to their roles.
In reporting on therapeutic alliance, patients score statements including:
f I have new ways of looking at my problems
f I have a better idea of how to make changes
f My therapist cares about me
f We agree on the important work
f We collaborate on setting goals
Alumni Experience
“The first few weeks were so hard! Eventually, my daughter made it through the first few stages of the program. Family therapy got better and easier. I saw a smile and laughter on her face that I hadn’t seen in months. It was then that I knew change was taking place—I could see it all over her face!”
—Charity N., alumni parent
Treatment Outcomes: Specific Patient Populations
Substance Use Disorders
Newport's treatment approach addresses each patient's mental health profile—not isolated to the primary diagnosis, but also treating related symptoms. Our treatment plans for patients with primary or secondary substance use disorder also treat trauma, family attachment ruptures, and co-occurring mental health issues.
In 2024, to assess the overall impact of our treatment on this group of patients, we looked at their anxiety, depression, and well-being scores over five weeks of residential treatment. For both adolescents and young adults with primary or secondary substance use disorder diagnoses, anxiety and depression improved, reaching mild levels, and well-being increased, with patients, on average, in the “well” range at discharge.
ADOLESCENT OUTCOMES
Obsessive-Compulsive Disorder (Y-BOCS/CY-BOCS)
Newport’s multidimensional treatment model for obsessivecompulsive disorder provides individualized care that also addresses common issues associated with OCD, like generalized anxiety, social anxiety, and phobias. Clinicians in our OCD-specific programming have extensive training and supervision in Exposure and Response Prevention (ERP) therapy, the gold standard of OCD treatment. Our treatment plans for OCD also include Attachment-Based Family Therapy, experiential therapy, and academics/life skills training to support all areas of each patient’s life and well-being.
In 2024, patients in our OCD-specific treatment programs were given the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and the Children’s Y-BOCS (CY-BOCS) assessments, in addition to our other screening tools. At intake, both adolescent and young adult patients reported severe OCD symptoms, on average. At discharge, adolescents’ symptoms had dropped into the mild range, on average, while our young adult patients’ mean score was in the moderate range. Average length of stay was 48 days for adolescents and 34 days for young adults. Young adult data includes results from three programs, two of which opened in 2024.
Alumni Experience
Interpretation of the Levels
24–31: Severe
16–23: Moderate
8–15: Mild
“The staff didn’t learn my case file, they got to know me—my interests, hopes, dreams, adventures, quirks, jokes, and how much of me was being consumed by my OCD. My clinical team, Care Coordinators, and peers became my Newport family, and it was in my relations with them that I found the strength to start decoupling myself from my OCD.”
—Andrew K.
Parent Post-Discharge Data
As well as tracking patients’ symptoms post-discharge, we survey their parental figures (which may include parents, stepparents, grandparents, etc.). Data from these family members adds another layer to our understanding of how patients and families progress after treatment. In 2024, Newport collected post-discharge data from parents of our adolescent and young adult patients, in both residential and outpatient programs. Results below are drawn from 30- and 90-day follow-up surveys.
Symptomology (PHQ-2 & GAD-2 & WHO-5)
At intake, parent-reported data showed that most patients were exhibiting elevated symptoms of depression and anxiety (>3 on a scale of 0–6 on both measures) and in the “poor” or “likely depression” range on the well-being scale. At 30 days and 90 days post-discharge, parents were no longer observing elevated depressive or anxiety symptoms in their children, and they were also seeing improvements in well-being.
Family Functioning
Parents experienced improvements across multiple areas of family functioning post-discharge, reporting that family members felt:
f More comfortable discussing emotions, including sadness
f Better able to work together to problem-solve
f Greater ease in planning family activities
f More inclined to turn to family for support
f More accepted for who they are
Snohomish, WA
The percentage of parents reporting a greater ability to problem-solve with their adolescent child doubled from intake to discharge (from 22% to 44%).
“We came to Newport broken, exhausted, and helpless. We came out with a new life. We are so grateful to the Newport team and the Newport parent community.”
—Pam R., alumni parent
TMS Depression Treatment at PrairieCare (PHQ-9)
PrairieCare, a Minnesota division of Newport Healthcare, offers a complete continuum of care at nine locations in the Twin Cities and Southern Minnesota: inpatient psychiatric hospitalization, residential and outpatient treatment, and clinic services, including Transcranial Magnetic Stimulation (TMS). TMS is an FDA-approved approach for treatment-resistant depression that has been available to the public since 2008. For patients with treatment-resistant depression, TMS has the potential to create lifechanging improvements in functioning, mood, and well-being.
In 2024, 188 patients had TMS treatment at PrairieCare’s two TMS clinics (some patients began treatment in late 2023 or continued into early 2025). On average, patients started treatment with a PHQ-9 score of about 15.4, indicating moderate to severe depression. After a typical course of 36 treatment sessions, patients’ average PHQ-9 score was approximately 9.7, indicating mild depression. This represents a 44% average increase from baseline—a meaningful improvement for most patients. The chart below tracks improvement among patients according to symptom severity at intake.
Mean Total Score by Treatment Number
Edina, MN
Over the course of treatment, half of PrairieCare's TMS patients experienced at least a 50% reduction in depressive symptoms.
Interpretation of the Levels
20–27: Severe
15–19: Moderately Severe
10–14: Moderate
5–9: Mild
The Newport Healthcare Experience
The Newport experience spans every aspect of the treatment journey, from the admissions process and customer service to quality of care and support after discharge.
Satisfaction with Care
In 2024, our patients, their parents, and referring professionals all reported high satisfaction, on average, with Newport’s quality of care, treatment services, and staff. Prioritizing human understanding and connection in our care enhances trust, communication, and collaboration, supporting us to fulfill our mission of providing resultsdriven, clinically integrated behavioral healthcare that creates hope, promotes sustainable healing, and fosters resiliency in individuals and families. Insights gained from our proprietary Newport Client Satisfaction ScaleTM also inform our initiatives to continually improve patients’ and families’ experiences.
Parents of Adolescents and Young Adults in All Programs
8 in 10 parents surveyed at discharge would recommend Newport to others
9 in 10 parents surveyed at week 3 felt that staff paid attention to their family's needs and goals
Patients
9 in 10
young adults in residential care felt welcomed and accepted
99% reported that they will continue to refer patients to Newport
8 in 10
adolescents felt they benefited from our residential or outpatient treatment
Referring Professionals
97% reported that the families they referred received excellent customer service
8 in 10
patients felt Newport staff took the time to understand them and their needs
95% reported that the clients they referred were given exceptional treatment
Appendix I: Assessment Tools
SCALE/SCREENER DOMAIN
C ENTERFOR RESEARC H &INNOVATION
BHS School, safety, substance use, sexual risk, suicide and selfharm, trauma, bullying
GAD-7
GAD-2 Anxiety
About the Center for Research and Innovation
The Center for Research and Innovation (CRI) is the research-focused arm of Newport Healthcare. One of the few institutions of its kind, the CRI establishes Newport as a thought leader in the field and an innovator in bridging science and clinical practice.
The CRI’s Mission and Objectives
PHQ-9
PHQ-2 Depression
WHO-5 Well-Being
ECR-RS Family Attachment
WAI-SR Working Alliance with Family Therapist
FAD-GF Family Functioning
CY-BOCS/ Y-BOCS Obsessive-Compulsive Disorder
The CRI’s purpose is to advance Newport Healthcare as a leader and innovator in treatment, research, and program development, through outcomes evaluation, data-informed care, and field-advancing studies. The CRI’s goals are to continually expand our understanding of our patient population and their needs, improve patient outcomes, and support the professional development of our staff, by providing opportunities to participate in research, presentations, and publications.
“Millions of adolescents and young adults are impacted by mental health concerns each year, and that vast number is doubled and tripled by the caregivers and communities impacted. Given how important treatment can be, and the severity of the youth and young adult mental health crisis, there is surprisingly little research on what works and why. The CRI is playing a role in changing that.”
